Advanced in Ewing Sarcoma
Advanced in Ewing Sarcoma
Childrens Specialty Group PLLC
601 Childrens Ln, 
Norfolk, VA 
 (231.9 mi)

Overview

Eric Lowe is a Pediatric Hematologist Oncology specialist and a Hematologist in Norfolk, Virginia. Dr. Lowe and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Anaplastic Large Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Hepatoblastoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 83 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 16 clinical trials in the study of Ewing Sarcoma.

Specialties
Pediatric Hematology Oncology
Hematology
Oncology
Licenses
Pediatrics in VA
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  UnitedHealthcare
  •  Humana
  •  Piedmont

Locations

CHILDRENS SPECIALTY GROUP PLLC
601 Childrens Ln, Norfolk, VA 23507

Additional Areas of Focus

Dr. Lowe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


82 Clinical Trials

A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Molecular Analysis for Therapy Choice (MATCH)
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
View 39 Less Clinical Trials
Similar Doctors
Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology
Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology

Virginia Oncology Associates

5838 Harbour View Blvd, Suite 105, 
Suffolk, VA 
 (7.7 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Cynthia Sile is a Hematologist Oncology specialist and a Hematologist in Suffolk, Virginia. Dr. Sile and is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Familial Colorectal Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Paget Disease of the Breast. Dr. Sile is currently accepting new patients.

Experienced in Ewing Sarcoma
Hematology | Oncology
Experienced in Ewing Sarcoma
Hematology | Oncology

Virginia Oncology Associates

744 Battlefield Blvd N, Suite 200, 
Chesapeake, VA 
 (8.5 mi)
Languages Spoken:
English, Mandarin
Accepting New Patients
Offers Telehealth

Valiant Tan is a Hematologist and an Oncologist in Chesapeake, Virginia. Dr. Tan and is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Bone Marrow Aspiration. Dr. Tan is currently accepting new patients.

Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology
Experienced in Ewing Sarcoma
Hematology Oncology | Hematology | Oncology

Virginia Oncology Associates

1051 Loftis Blvd, Suite 100, 
Newport News, VA 
 (18.4 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Cristina Alencar is a Hematologist Oncology specialist and a Hematologist in Newport News, Virginia. Dr. Alencar and is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Paget Disease of the Breast, Large-Cell Immunoblastic Lymphoma, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Alencar is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile